Mar 14th, 2025

Watch: Welcome to Seattle

We are glad you are here to multiply your impact.

Sgo26 Awards Donor Appreciationand Research

2026 Research Awards and Donor Appreciation

Karen Lu, MD

Get to Know SGO’s Incoming President

audience shot

A Potential New Detection Tool for Invasive Cervical Cancer

Ginger Gardner, MD, FACOG

Empowering Progress: The Foundation for Women's Cancer

A Potential Second-Line Treatment for Cervical Cancer

Tamar Gootzen, MD

An Alternative Approach to Preventing Ovarian Cancer?

Fang Jiang, MD, PhD

Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia

Angela Nolin, MD

It’s Time to Change the Diagnosis Protocol for Endometrial Cancer

Matthew A. Powell, MD

Tricky But Treatable

Kathleen N. Moore, MD

Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment

Linda Duska, MD, MPH

Pembrolizumab Plus Chemotherapy Regimen Yields Clinically Positive Outcomes for Treatment of Locally Advanced Cervical Cancer

headshots of the program chairs

Masterclasses and Hands-On Learning Set the Pace for SGO 2025